These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21242336)

  • 1. Materials scientists join oncologists to explore nano- and microtherapeutics.
    Martin M
    J Natl Cancer Inst; 2011 Feb; 103(3):172-3, 177. PubMed ID: 21242336
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanoimaging devices illuminate tumor margins during surgery.
    Patlak M
    J Natl Cancer Inst; 2011 Feb; 103(3):173-4. PubMed ID: 21242334
    [No Abstract]   [Full Text] [Related]  

  • 3. Thinking small: nanotechnology offers new options for cancer treatment and management.
    Dolan TB
    ONS Connect; 2011 Feb; 26(2):17. PubMed ID: 21388022
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanotechnology: Future of Oncotherapy.
    Gharpure KM; Wu SY; Li C; Lopez-Berestein G; Sood AK
    Clin Cancer Res; 2015 Jul; 21(14):3121-30. PubMed ID: 26180057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Materials and biology. Nanotechnology takes aim at cancer.
    Service RF
    Science; 2005 Nov; 310(5751):1132-4. PubMed ID: 16293748
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists.
    Berchuck A
    J Clin Oncol; 2007 Aug; 25(23):3552; author reply 3557-8. PubMed ID: 17687164
    [No Abstract]   [Full Text] [Related]  

  • 7. Bibliometric analysis of nanotechnology applied in oncology from 2002 to 2011.
    Dong X; Qiu XC; Liu Q; Jia J
    Tumour Biol; 2013 Dec; 34(6):3273-8. PubMed ID: 23959469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology treats cancer at the atomic level.
    Gaguski ME
    ONS Connect; 2008 Jul; 23(7):23. PubMed ID: 18697650
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
    Vergote I; Amant F; Leunen K
    Gynecol Oncol; 2010 Oct; 119(1):1-2. PubMed ID: 20833283
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
    Harlozinska A; Bar JK; Richter R; Cislo M
    Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascitic fluid cytology in a case of metastatic malignant mixed mesodermal tumor of the ovary.
    Silverman JF; Gardner J; Larkin EW; Finley JL; Norris HT
    Acta Cytol; 1986; 30(2):173-6. PubMed ID: 3457508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.
    Barker SD; Casado E; Gomez-Navarro J; Xiang J; Arafat W; Mahasreshti P; Pustilnik TB; Hemminki A; Siegal GP; Alvarez RD; Curiel DT
    Gynecol Oncol; 2001 Jul; 82(1):57-63. PubMed ID: 11426962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The establishment of human ovarian carcinoma cell line HO-8910 and its characteristics].
    Mou HZ; Xu SH; Zhang YY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Mar; 29(3):162-4, 191. PubMed ID: 8082435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite.
    Yin H; Too HP; Chow GM
    Biomaterials; 2005 Oct; 26(29):5818-26. PubMed ID: 15949547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 4 - Applications of nanotechnology in molecular imaging of the brain.
    McAteer MA; Choudhury RP
    Prog Brain Res; 2009; 180():72-96. PubMed ID: 20302829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic importance of tumor cell detection in exudates and peritoneal lavage fluid by monolayer cultures].
    Kurbacher CM; Breuel C; Kurbacher J; Jäger W; Wildt L; Lang N
    Gynakol Rundsch; 1991; 31 Suppl 2():369-70. PubMed ID: 1790982
    [No Abstract]   [Full Text] [Related]  

  • 18. A step towards a new targeted nanotherapy for pancreatic cancer.
    Keen J
    Cancer Biol Ther; 2008 Oct; 7(10):1591-2. PubMed ID: 18769119
    [No Abstract]   [Full Text] [Related]  

  • 19. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
    McGowan L
    Obstet Gynecol; 1989 Jan; 73(1):136-7. PubMed ID: 2909035
    [No Abstract]   [Full Text] [Related]  

  • 20. Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.
    Brioschi AM; Calderoni S; Zara GP; Priano L; Gasco MR; Mauro A
    Prog Brain Res; 2009; 180():193-223. PubMed ID: 20302836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.